Showing 551-560 of 1742 results for "".
Medical Marijuana and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-parkinsons-disease/30245/Given limited treatments available, investigating potential benefits of cannabinoids can offer cautious optimism over controversy.Movement Disorders Moment: Shining a Light on the Off Periods of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-shining-a-light-on-the-off-periods-of-parkinsons-disease/30175/New formulations for rescue from the off period are coming.Case Report: Leber Hereditary Optic Neuropathy in a 60-Year-Old Man with Vitamin B12 Deficiency
https://practicalneurology.com/diseases-diagnoses/tbi/case-report-leber-hereditary-optic-neuropathy-in-a-60-year-old-man-with-vitamin-b12-deficiency/30849/LHON should be considered as a diagnosis in patients, regardless of age, with unexplained bilateral optic neuropathy and central vision loss.The Sunshine Act Inevitably Rises
https://practicalneurology.com/columns/practice-management/the-sunshine-act-inevitably-rises/30669/2014's key implementation dates and how physicians can be better prepared for them.Bionic Breakout: Robotic-Assisted Therapy Is Evolving
https://practicalneurology.com/columns/practice-management/bionic-breakout-robotic-assisted-therapy-is-evolving/30726/Robotic-assisted therapy has made significant strides in the past 15 years. Will it overtake conventional physical therapy?Lewy Body Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/lewy-body-dementia-1/31536/The second highest cause of dementia is highly variable.Behavioral and Integrative Therapies for Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/behavioral-and-integrative-therapies-for-headache/31518/Many patients who may benefit from these treatments may not be aware nonpharmacologic approaches exist.Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Atrial Cardiopathy and Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/atrial-cardiopathy-and-stroke/31614/The past decade there has been a resurgence in understanding of the relationship of atrial fibrillation to stroke.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.